1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 98%, 50mg

2-(1H-1,2,4-Triazol-3-yl)pyridine>98.0%(GC)(T)1g

6-Amino-1,2-benzisoxazole, 95.0%, 1g

(S)-1-(Trifluoromethyl)ethylisocyanate, 5g

1-Methyl-3,5-diphenyl-1H-1,2,4-triazole, 98.0%, 1g

1,3-dimethyl-1,6-dihydro-2H-pyrrolo[3,4-d]pyrimidine-2,4(3H)-dione, 95.0%, 500mg

2,2'-(1,3-Dioxolane-2,2-diyl)diethanol, 95.0%, 100mg

(2R,5R)-tert-Butyl 5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate, 95.0%, 100mg

Phase contrast slide set with 10x and S40x PLPHi IOS infinity corrected objectives and phase contrast rings for 10x/S40x

Pentafluoropropionic Acid (ca. 0.5mol/L in Water) [Ion-Pair Reagent for LC-MS]10mL

4-(Difluoromethoxy)nitrobenzene, 97.0%, 25g

4-Chlorosulfonylpyrazole, 97.0%, 10g

4-(4-Hexylbenzoyl)isoquinoline, 97.0%, 1g